Scope | Domain | Final recommendation (Ref.) | Priority1 | Source guideline(s) |
---|---|---|---|---|
Diagnosis | Diagnostic tool | 1. The reduced Cariogram software (without saliva tests), or the CAMBRA form (in the absence of the reduced Cariogram software) is recommended for caries risk assessment in adults [11,12,13, 44] | 1 | – |
Preventive measure | Fluoride concentration of toothpaste | 2. For low-risk adults, toothbrushing twice a day, using over the counter fluoride toothpastes (1000–1450 ppm F) is recommended [9, 20, 42, 44, 45, 48, 58, 68,69,70,71] | 1 | Malaysian |
CAMBRA | ||||
CariesCare | ||||
ICCMS | ||||
CMS | ||||
3. For medium-risk adults, toothbrushing twice a day, using over the counter fluoride toothpastes (1000–1450 ppm F) is recommended [20, 42, 44, 45, 48, 58, 68,69,70,71] | 1 | Malaysian | ||
CAMBRA | ||||
CariesCare | ||||
CMS | ||||
4. For high-risk adults, toothbrushing twice a day, using high fluoride toothpastes (1450 ppm F or more) is recommended [42, 44, 45, 72,73,74,75] | 1 | Malaysian | ||
CariesCare | ||||
ICCMS | ||||
5. For extreme-risk adults, toothbrushing twice a day, using high fluoride toothpastes (1450 ppm F or more) is recommended [42, 44, 45, 72,73,74,75] | 1 | Malaysian | ||
CariesCare | ||||
ICCMS | ||||
Sodium fluoride mouthrinse | 6. For low-risk adults, use of NaF mouthrinse is not recommended [9, 18, 20, 48, 58, 68, 76, 77] | 1 | CAMBRA | |
ICCMS | ||||
CMS | ||||
7. For medium-risk adults, daily use of 220 ppm NaF mouthrinse or weekly use of 900 ppm NaF mouthrinse, at a time other than brushing and with 1 min duration, is recommended [9, 18, 20, 48, 58, 68, 76, 77] | 1 | CAMBRA | ||
ICCMS | ||||
CMS | ||||
8. For high-risk adults, daily use of 220 ppm NaF mouthrinse or weekly use of 900 ppm NaF mouthrinse, at a time other than brushing and with 1 min duration, is recommended [9, 18, 20, 48, 58, 68, 76, 77] | 1 | ICCMS2 | ||
9. For extreme-risk adults, daily use of 220 ppm NaF mouthrinse or weekly use of 900 ppm NaF mouthrinse, at a time other than brushing and with 1 min duration, is recommended [9, 18, 20, 48, 58, 68, 76, 77] | 1 | ICCMS2 | ||
Chlorhexidine mouthrinse | 10. For low-risk adults, use of chlorhexidine mouthrinse is not recommended [20, 48, 58] | 1 | CAMBRA | |
CMS | ||||
11. For medium-risk adults, use of chlorhexidine mouthrinse is not recommended [20, 48, 58] | 1 | CAMBRA | ||
CMS | ||||
12. For high-risk adults, daily use of %0.12 chlorhexidine gluconate mouthrinse for 1 week in each month, at least 1 h apart from tooth brushing and with 1 min duration, is recommended [20, 48, 58] | 1 | CAMBRA | ||
13. For extreme-risk adults, daily use of %0.12 chlorhexidine gluconate mouthrinse for 1 week in each month, at least 1 h apart from tooth brushing and with 1 min duration, is recommended [20, 32, 48, 58] | 1 | CAMBRA | ||
CMS | ||||
Fluoride varnish | 14. For low-risk adults, routine application of fluoride varnish is not recommended [20, 48, 58] | 1 | CAMBRA | |
15. For medium-risk adults, application of fluoride varnish, every 6 months, is recommended [18, 59, 77, 78] | 1 | ICCMS | ||
16. For high-risk adults, application of fluoride varnish, every 4–6 months, is recommended [18, 20, 48, 58, 59, 77, 78] | 1 | CAMBRA | ||
ICCMS | ||||
17. For extreme-risk adults, application of fluoride varnish, every 3–4 months, is recommended [18, 20, 48, 58, 59, 77, 78] | 1 | CAMBRA | ||
ICCMS | ||||
In office fluoride gel3 | 18. For low-risk adults, routine application of NaF gel is not recommended [18, 50, 77] | 1 | ICCMS | |
19. For medium-risk adults, application of %2 NaF gel at office is recommended [18, 50, 77] | 2 | ICCMS | ||
20. For high-risk adults, application of %2 NaF gel at office is recommended [18, 50, 77] | 1 | ICCMS | ||
21. For extreme-risk adults, application of % NaF gel at office is recommended [18, 50, 77] | 1 | ICCMS | ||
At home fluoride gel | 22. For extreme-risk adults, in case of caries progression despite receiving toothpaste, mouthrinse and varnish, daily application of 5000 ppm fluoride gel by at-home trays, with 5-min duration, is recommended [20, 48, 58] | 1 | CAMBRA | |
Mouth buffering | 23. For extreme-risk adults, ad libitum rinsing of the mouth with water and baking soda (2 tea spoons in 250 ml water) is recommended [20, 48, 58, 79] | 1 | CAMBRA | |
Pit and fissure sealants | 24. For medium-risk adults, sealant application in caries-prone areas is recommended [17, 33, 55, 80,81,82] | 4 | CariesCare | |
ICCMS | ||||
25. For high-risk adults, sealant application in caries-prone areas is recommended [17, 33, 55, 80,81,82] | 1 | CariesCare | ||
ICCMS | ||||
26. For extreme-risk adults, sealant application in caries-prone areas is recommended [17, 33, 55, 80,81,82] | 1 | CariesCare | ||
ICCMS | ||||
Operative treatment threshold | ICDAS 1,2 occlusal lesions (Incipient caries without dentine involvement or obvious cavity) | 27. For low-risk adults, ICDAS 1,2 occlusal lesions (incipient caries without dentine involvement or obvious cavity), if are active, should be managed non-operatively and if are inactive, should be assessed at follow-up sessions for any changes [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare |
CMS | ||||
28. For medium-risk adults, ICDAS 1,2 occlusal lesions if are active, should be managed non-operatively and if are inactive, should be assessed at follow-up sessions for any changes [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
29. For high-risk adults, ICDAS 1,2 occlusal lesions, if are active, should be managed non-operatively and if are inactive, should be assessed in follow-up sessions for any change [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
30. For extreme-risk adults, ICDAS 1,2 occlusal lesions, if are active, should be managed non-operatively and if are inactive, should be assessed at follow-up sessions for any changes [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
ICDAS 3 occlusal lesions (Enamel micro-cavities without an underlying dentin shadow) | 31. For low-risk adults, ICDAS 3 occlusal lesions can be managed non-operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | |
CMS | ||||
32. For medium-risk adults, ICDAS 3 occlusal lesions can be managed non-operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
33. For high-risk adults, ICDAS 3 occlusal lesions can be managed non-operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
34. For extreme-risk adults, ICDAS 3 occlusal lesions can be managed non-operatively (33, 53–56, 81–85) | 4 | CariesCare | ||
CMS | ||||
ICDAS 4 occlusal lesions (Enamel micro-cavities with an underlying dentin shadow) | 35. For low-risk adults, ICDAS 4 occlusal lesions can be managed non-operatively, only if the lesion is inactive and the radiolucency does not engage the whole outer third of dentine [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | |
CMS | ||||
36. For medium-risk adults, ICDAS 4 occlusal lesions should be managed operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
37. For high-risk adults, ICDAS 4 occlusal lesions should be managed operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
38. For extreme-risk adults, ICDAS 4 occlusal lesions should be managed operatively [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
C1, C2 proximal lesions (Outer half and inner half of enamel) | 39. For low-risk adults, C1, C2 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | |
CMS | ||||
40. For medium-risk adults, C1, C2 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
41. For high-risk adults, C1, C2 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 2 | CariesCare | ||
CMS | ||||
42. For extreme-risk adults, C1, C2 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 2 | CariesCare | ||
CMS | ||||
C3 proximal lesions (Just into dentinoenamel junction) | 43. For low-risk adults, C3 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 4 | CariesCare | |
CMS | ||||
44. For medium-risk adults, C3 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended [33, 53,54,55,56, 81,82,83,84,85] | 4 | CariesCare | ||
CMS | ||||
45. For high-risk adults, operative management of C3 proximal lesions is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
46. For extreme-risk adults, operative management of C3 proximal lesions is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
C4 proximal lesions (Outer third of dentin | 47. For low-risk adults, C4 proximal lesions do not need restoration, application of topical fluoride and follow-up is recommended only if the radiolucency does not engage the whole outer third of dentine and there is no cavity after teeth separation. Otherwise, operative management is recommended [33, 53,54,55,56, 81,82,83,84,85] | 4 | CariesCare | |
CMS | ||||
48. For medium-risk adults, operative management of C4 proximal lesions is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
49. For high-risk adults, operative management of C4 proximal lesions is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
50. For extreme-risk adults, operative management of C4 proximal lesions is recommended [33, 53,54,55,56, 81,82,83,84,85] | 1 | CariesCare | ||
CMS | ||||
Follow up | Follow up interval | 51. For low-risk adults, 12 months follow-up interval is recommended [20, 48, 57,58,59, 86] | 1 | CAMBRA |
52. For medium-risk adults, 6 months follow-up interval is recommended [20, 48, 57,58,59, 86] | 1 | Malaysian | ||
CAMBRA | ||||
CMS | ||||
53. For high-risk adults, 4–6 months follow-up interval is recommended [20, 48, 57,58,59, 86] | 1 | CAMBRA | ||
54. For extreme-risk adults, 3–4 months follow-up interval is recommended [20, 48, 57,58,59, 86] | 1 | CAMBRA | ||
CMS |